Key Insights

Highlights

Success Rate

76% trial completion

Published Results

27 trials with published results (8%)

Research Maturity

91 completed trials (28% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

9.0%

29 terminated out of 324 trials

Success Rate

75.8%

-10.7% vs benchmark

Late-Stage Pipeline

4%

14 trials in Phase 3/4

Results Transparency

30%

27 of 91 completed with results

Key Signals

27 with results76% success29 terminated

Data Visualizations

Phase Distribution

230Total
Not Applicable (79)
Early P 1 (7)
P 1 (85)
P 2 (45)
P 3 (12)
P 4 (2)

Trial Status

Recruiting94
Completed91
Unknown47
Active Not Recruiting30
Terminated29
Withdrawn19

Trial Success Rate

75.8%

Benchmark: 86.5%

Based on 91 completed trials

Clinical Trials (324)

Showing 20 of 20 trials
NCT04774198CompletedPrimary

Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy

NCT06051695Phase 1Recruiting

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT05403177Recruiting

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

NCT07494994Not ApplicableNot Yet RecruitingPrimary

SURGIMEDIA: Utilization of Multimedia for Enhanced Surgical Consent

NCT06158139Phase 1RecruitingPrimary

Autologous CAR-T Cells Targeting B7-H3 in PDAC

NCT05964361Phase 1Completed

First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients

NCT04981119Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT04594772Phase 2Active Not RecruitingPrimary

Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma

NCT01915225Recruiting

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

NCT07612046Recruiting

A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening

NCT07608458Not ApplicableNot Yet Recruiting

Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy

NCT06263088Not ApplicableRecruiting

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

NCT06593431Phase 3RecruitingPrimary

Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial

NCT07596732Not ApplicableNot Yet Recruiting

Statewide Unified Network for Remote Intervention of Strength and Exercise

NCT06252545Not ApplicableRecruitingPrimary

Promoting CT Engagement for Pancreatic Cancer With App

NCT06549751Phase 1Not Yet RecruitingPrimary

MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer

NCT04902872Phase 1Completed

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

NCT07436312Not ApplicableRecruiting

Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer

NCT04331041Phase 2Active Not RecruitingPrimary

Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma

NCT05111353Phase 1CompletedPrimary

Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery

Scroll to load more

Research Network

Activity Timeline